ndc for semaglutide Last week's expiry of the patent semaglutide—the active ingredient in Novo Nordisk's blockbuster drugs that are used to treat both diabetes and obesity—unleashed a flurry of launches of low-cost generic versions FDA ends semaglutide shortage, closing

Small observational studies and case reports have examined outcomes in patients with type 2 diabetes and concurrent IBD who were prescribed GLP-1 agonists for glycemic control

doi: 10.1016/j.tem.2020.02.006 133 LudwigDSEbbelingCB

Seek urgent assessment via NHS 111, eye casualty/A&E, or your GP if you experience: Sudden vision loss or significant deterioration in either eye Floaters (new dark spots or strings drifting through your vision), especially if numerous or increasing Flashes of light in your peripheral vision A curtain or shadow moving across your visual field Distorted vision where straight lines appear wavy or bent Difficulty reading or recognising faces that develops rapidly Blurred vision that doesn't improve with blinking or resting your eyes Eye pain with vision changes or a red, painful eye These symptoms may indicate complications such as vitreous haemorrhage (bleeding into the gel-filled centre of the eye), retinal detachment , or diabetic macular oedema (swelling of the central retina)

Food simply becomes less of a preoccupation